TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

205.90$ +0.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Revolution Medicines Inc (RVMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 4,323 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RVMD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
984 2,062 1,908 1,808 1,763 2,558 2,365 2,430 2,252 2,355 2,254 4,323
824 1,879 1,729 1,625 1,579 2,328 2,135 2,176 1,977 2,075 1,968 4,028
358 696 288 276 201 543 334 402 217 384 441 815
813 1,853 1,704 1,591 1,549 2,289 2,103 2,137 1,932 2,026 1,908 3,938
0.3 1.3 0.0 0.0 0.0 0.0 – – – – – –
0.0 0.0 – – – – – – – – – –
15 15 15 15 15 15 15 15 15 15 15 15
58 58 57 57 57 57 56 56 56 56 56 56
147 236 183 190 197 293 287 564 655 723 754 1,717
86 144 94 105 111 164 159 185 246 290 290 354
5.8 7.4 8.2 8.3 8.4 13 13 13 16 16 17 17
30 62 32 29 24 54 48 57 75 65 81 88
– – – – – – – – – – – 487
837 1,826 1,725 1,619 1,566 2,265 2,078 1,865 1,597 1,631 1,500 2,606
-976 -1,138 -1,254 -1,387 -1,543 -1,738 -1,951 -2,199 -2,504 -2,869 -3,323 -3,967
109 141 165 165 167 168 188 188 189 190 198 211

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?